The ureteral access sheath market is driven by the rising prevalence of urological disorders, such as kidney stones and ureteral strictures, which necessitate endoscopic procedures. Ureteral access ...

Healthcare professional (HCP) engagement is a term known to everyone who’s trying to win attention in the domain of pharma ... MSD and Daiichi Sankyo's patritumab deruxtecan hit its main ...

In addition to supporting its own efforts, Pfizer plans to make available to the wider academic community some of the molecular mechanics parameters it will generate with public-domain compounds.

Activation of macrophage TLR4 by bacterial endotoxins is important for the progression of sepsis, but the underlying ...

The Centre's ambitious research agenda focuses on five everyday Domains of Sociodigital Practice. These projects explore how digital devices, services and data are shaping - and being shaped by - the ...

BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)--The HERTHENA-Lung02 phase 3 trial evaluating patritumab deruxtecan in patients with locally advanced or metastatic EGFR-mutated non-small cell ...

Merck & Co Inc. (MRK) on Tuesday said HERTHENA-Lung02 phase 3 study evaluating Daiichi Sankyo and Merck's patritumab deruxtecan in ...